Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> SHIRE PLC Latest News

MAR 05, 2015 - Yahoo! News

A Must Read - Share

AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal

AbbVie Inc is to buy Pharmacyclics Inc for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. The deal -- the latest example of a big drugmaker swooping on a biotech firm to refill its medicine pipeline -- confounds expectations that ...

Tags: AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal,  Shire Plc Latest News

MAR 05, 2015 - Yahoo! News

A Must Read - Share

AbbVie to buy Pharmacyclics for $21 billion to boost cancer drugs pipeline

(Reuters) - Drugmaker AbbVie Inc said it will buy Pharmacyclics Inc , the maker of blockbuster cancer drug Imbruvica, for about $21 billion to broaden its oncology drugs pipeline. The deal gives AbbVie access to Pharmacyclics' cancer drugs portfolio, lessening the Chicago-based company's dependence on its rheumatoid arthritis drug Humira that accounts for most of its sales. The transaction follows ...

Tags: AbbVie to buy Pharmacyclics for $21 billion to boost cancer drugs pipeline,  Shire Plc Latest News

FEB 20, 2015 - Business Insider

A Must Read - Share

Drugmaker Valeant close to buying Salix: source

By Nadia DamouniNEW YORK (Reuters) - Valeant Pharmaceuticals International Inc is close to a deal to acquire bowel drug maker Salix Pharmaceuticals Ltd for around $160 per share, according to a person directly familiar with the matter.An agreement could come as early as next week, the source said on Friday, who requested not to be identified as the matter is ...

Tags: Drugmaker Valeant close to buying Salix: source,  Shire Plc Latest News

FEB 13, 2015 - Zacks Investment Research

A Must Read - Share

Shire Misses on Q4 Earnings, Revenues Beat; Shares Rise - Analyst Blog

Shire plc (SHPG) reported fourth-quarter 2014 earnings (excluding special items and amortization) of $2.63 per American Depositary Share (ADS), missed the Zacks Consensus Estimate of $2.66.

Tags: Shire Misses on Q4 Earnings, Revenues Beat; Shares Rise - Analyst Blog,  Shire Plc Latest News